首页|基于肺腺癌脑转移瘤CT灌注成像参数对肺腺癌EGFR基因突变状态预测的初步研究

基于肺腺癌脑转移瘤CT灌注成像参数对肺腺癌EGFR基因突变状态预测的初步研究

A preliminary study on the prediction of EGFR gene mutation status in lung adenocarcinoma based on CT perfusion imaging parameters of brain metastases

扫码查看
目的:应用肺腺癌患者脑转移瘤的CT灌注成像参数预测肺腺癌表皮生长因子受体(EGFR)基因的突变状态.方法:回顾性分析接受治疗并完成肺癌病理及EGFR基因检测的45例肺腺癌脑转移患者(EGFR突变型26例,EGFR野生型19例).所有患者均行颅脑CT灌注成像,应用颅脑CT灌注图像分割强化肿瘤和瘤周水肿,提取CT灌注参数.应用具有显著相关性的灌注参数预测EGFR基因的突变状态.采用ROC曲线评估脑转移瘤CT灌注成像参数预测肺腺癌EGFR基因突变状态的效能.结果:灌注参数中,脑血流量(CBF)和平均通过时间(MTT)在肺腺癌2种EGFR基因突变状态中差异均有统计学意义(均P<0.05).CBF和MTT联合预测肺腺癌EGFR基因突变状态的AUC为0.790.结论:原发性肺腺癌患者脑转移瘤的CT灌注成像参数可用于预测EGFR突变状态.
Objective:To apply CT perfusion imaging parameters of brain metastases in patients with lung adenocarcinoma to classify the mutation status of the epidermal growth factor receptor(EGFR)gene.Methods:Forty-five patients with brain metastases in lung adenocarcinoma were retrospectively analyzed,26 cases were EGFR mutation and 19 cases were EGFR wild-type.All patients underwent cranial CT perfusion imaging,and CT perfusion parameters from the enhanced tumor and peritumoral edema were extracted.Perfusion parameters with significant correlations were applied to classify EGFR mutation and ROC curve was used to assess the efficiency.Results:Among the perfusion parameters,cerebral blood flow(CBF)and mean transit time(MTT)had significant differences between EGFR mutation and the wild-type(both P<0.005).The AUC of the CBF and MTT comodeling for classifying EGFR mutation status was 0.790.Conclusion:CT perfusion imaging parameters of brain metastases in patients with primary lung adenocarcinoma can be used to classify EGFR mutation status.

Tomography,X-ray computedPerfusion imagingBrain metastasesEpidermal growth factor receptorGene mutation

姜春成、姜中华、刘歆、曲倩倩、王云强

展开 >

山东省烟台市中医医院影像科,山东 烟台 264013

山东省烟台市中医医院肿瘤科,山东 烟台 264013

体层摄影术,X线计算机 灌注成像 脑转移瘤 表皮生长因子受体 基因突变

烟台市科技计划项目烟台市科技计划项目

2022YD0912020YD053

2024

中国中西医结合影像学杂志
中国中西医结合学会,山东中医药大学附属医院

中国中西医结合影像学杂志

CSTPCD
影响因子:0.857
ISSN:1672-0512
年,卷(期):2024.22(2)
  • 16